Cargando…
Infarct Volumes of Patients with Acute Ischemic Stroke Receiving Direct Oral Anticoagulants due to Non-Valvular Atrial Fibrillation
Direct oral anticoagulants (DOACs) have been shown to decrease the risk of ischemic stroke in non-valvular atrial fibrillation (NVAF). This study aims to investigate whether DOACs result in a significant change in lesion volume and the severity of the subsequent disability in patients who have exper...
Autores principales: | Yavasoglu, Nese G., Eren, Yasemin, Tatar, Idil G., Yalcınkaya, Irfan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061530/ https://www.ncbi.nlm.nih.gov/pubmed/33911376 http://dx.doi.org/10.4103/aian.AIAN_568_20 |
Ejemplares similares
-
Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012) -
Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014) -
Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation
por: Yamato, Hiroshi, et al.
Publicado: (2020) -
Clinical features and outcomes of patients in different age groups with non-valvular atrial fibrillation receiving oral anticoagulants
por: O, U Fan, et al.
Publicado: (2022) -
Prior Direct Oral Anticoagulant Therapy is Related to Small Infarct Volume and No Major Artery Occlusion in Patients With Stroke and Non‐Valvular Atrial Fibrillation
por: Sakamoto, Yuki, et al.
Publicado: (2018)